JPRN-UMIN000001583
Completed
未知
Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancer - Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancer
Kyushu Breast Cancer Study Group0 sites45 target enrollmentDecember 17, 2008
ConditionsBreast cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Breast cancer
- Sponsor
- Kyushu Breast Cancer Study Group
- Enrollment
- 45
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Clinical or radiological evidence of metastatic breast cancer 2\. complication of the active other malignancies 3\. Serious cardiac disfunction 4\. Uncontrolled medical conditions 5\. Significant interstitial pneumonia or pulmonary fibrosis by CT scan or X\-ray 6\. Patients who are required concurrent treatment by corticosteroids except for premedication 7 .Severe psychiatric disorders 8\. Pregnant or lactation women, or women with suspected pregnancy 9\. History of hypersensitivity reaction to drug formulated with Polysorbate 80 10\. Patients judged by the investigator to be unfit to be enrolled into the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancerrectal cancerJPRN-UMIN000003428Toho University school of medicine20
Completed
Phase 2
A trial of prospective adjuvant chemotherapy in patients with resectable colorectal cancer with heaptic metastasisResectable colorectal cancer with hepatic metastasisJPRN-UMIN000014492Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine40
Completed
Phase 2
Feasibility trial of neoadjuvant chemotherapy with docetaxel,cisplatin and fluorouracil for clinical stage II/III esophageal carcinoma.esophageal neoplasmJPRN-UMIN000002396Saitama Cancer Center40
Completed
Not Applicable
A feasibility study of neoadjuvant chemotherapy with docetaxel+cisplatin+capecitabine (DCX) for HER2-negative gastric cancer with macroscopic type 4 and large type 3, or with multiple lymph node metastasisGastric cancerJPRN-UMIN000026783agoya University20
Completed
Phase 3
A randomized trial of adjuvant chemotherapy in resected stage I lung adenocarcinoma with high SUV index. JNETS 1201ung cancerJPRN-UMIN000007790Japanese Northern East Area Thoracic Surgery Study Group (JNETS-SG)460